Bad Company: Microenvironmentally Mediated Resistance to Targeted Therapy in Melanoma

od Almeida, Filipe V, Douglass, Stephen M., Fane, Mitchell E., Weeraratna, Ashani T.
Wydane w Pigment Cell Melanoma Res (2018)

Genetic screening for single-cell variability modulators driving therapy resistance

od Torre, Eduardo A., Arai, Eri, Bayatpour, Sareh, Jiang, Connie L., Beck, Lauren E., Emert, Benjamin L., Shaffer, Sydney M., Mellis, Ian A., Fane, Mitchell E., Alicea, Gretchen M., Budinich, Krista A., Weeraratna, Ashani T., Shi, Junwei, Raj, Arjun
Wydane w Nat Genet (2021)

NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF

od Fane, Mitchell E., Chhabra, Yash, Hollingsworth, David E.J., Simmons, Jacinta L., Spoerri, Loredana, Oh, Tae Gyu, Chauhan, Jagat, Chin, Toby, Harris, Lachlan, Harvey, Tracey J., Muscat, George E.O., Goding, Colin R., Sturm, Richard A, Haass, Nikolas K., Boyle, Glen M., Piper, Michael, Smith, Aaron G.
Wydane w EBioMedicine (2017)

Changes in Aged Fibroblast Lipid Metabolism Induce Age-dependent Melanoma Cell Resistance to Targeted Therapy Via the Fatty Acid Transporter FATP2

od Alicea, Gretchen M., Rebecca, Vito W., Goldman, Aaron R., Fane, Mitchell E., Douglass, Stephen M., Behera, Reeti, Webster, Marie R., Kugel, Curtis H., Ecker, Brett L., Caino, M. Cecilia, Kossenkov, Andrew V., Tang, Hsin-Yao, Frederick, Dennie T., Flaherty, Keith T., Xu, Xiaowei, Liu, Qin, Gabrilovich, Dmitry I., Herlyn, Meenhard, Blair, Ian A., Schug, Zachary T., Speicher, David W., Weeraratna, Ashani T.
Wydane w Cancer Discov (2020)

Paradoxical role for wild type p53 in driving therapy resistance in melanoma

od Webster, Marie R, Fane, Mitchell E, Alicea, Gretchen M, Basu, Subhasree, Kossenkov, Andrew V, Marino, Gloria E, Douglass, Stephen M, Kaur, Amanpreet, Ecker, Brett L, Gnanapradeepan, Keerthana, Ndoye, Abibatou, Kugel, Curtis, Valiga, Alexander, Palmer, Jessica, Liu, Qin, Xu, Xiaowei, Morris, Jessicamarie, Yin, Xiangfan, Wu, Hong, Xu, Wei, Zheng, Cathy, Karakousis, Giorgos C, Amaravadi, Ravi K, Mitchell, Tara C, Almeida, Filipe V, Xiao, Min, Rebecca, Vito W, Wang, Ying-Jie, Schuchter, Lynn M, Herlyn, Meenhard, Murphy, Maureen E, Weeraratna, Ashani T
Wydane w Mol Cell (2019)

Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma

od Webster, Marie R., Fane, Mitchell E., Alicea, Gretchen M., Basu, Subhasree, Kossenkov, Andrew V., Marino, Gloria E., Douglass, Stephen M., Kaur, Amanpreet, Ecker, Brett L., Gnanapradeepan, Keerthana, Ndoye, Abibatou, Kugel, Curtis, Valiga, Alexander, Palmer, Jessica, Liu, Qin, Xu, Xiaowei, Morris, Jessicamarie, Yin, Xiangfan, Wu, Hong, Xu, Wei, Zheng, Cathy, Karakousis, Giorgos C., Amaravadi, Ravi K., Mitchell, Tara C., Almeida, Filipe V., Xiao, Min, Rebecca, Vito W., Wang, Ying-Jie, Schuchter, Lynn M., Herlyn, Meenhard, Murphy, Maureen E., Weeraratna, Ashani T.
Wydane w Mol Cell (2020)